| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 46.114 | 45.016 | 35.602 | 20.557 | 0 | - | - | - | - | - |
| Total Income - EUR | 46.220 | 45.310 | 35.603 | 20.558 | 0 | - | - | - | - | - |
| Total Expenses - EUR | 52.637 | 48.546 | 45.216 | 29.517 | 27 | - | - | - | - | - |
| Gross Profit/Loss - EUR | -6.418 | -3.237 | -9.613 | -8.959 | -27 | - | - | - | - | - |
| Net Profit/Loss - EUR | -7.276 | -3.553 | -9.827 | -9.136 | -27 | - | - | - | - | - |
| Employees | 5 | 5 | 5 | 0 | 0 | - | - | - | - | - |
Check the financial reports for the company - Maetrys Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.568 | 4.515 | 3.806 | 3.359 | 3.294 | - | - | - | - | - |
| Current Assets | 38.279 | 51.876 | 67.116 | 71.187 | 69.825 | - | - | - | - | - |
| Inventories | 9 | 20 | 20 | 2 | 2 | - | - | - | - | - |
| Receivables | 33.937 | 49.207 | 63.542 | 71.170 | 69.792 | - | - | - | - | - |
| Cash | 4.333 | 2.649 | 3.554 | 15 | 31 | - | - | - | - | - |
| Shareholders Funds | -19.712 | -23.065 | -32.501 | -41.041 | -40.200 | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | 61.560 | 79.455 | 103.423 | 115.588 | 113.319 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Maetrys Med Srl